Olympus Reveals iTind Center of Excellence Program

Olympus Corp. of the Americas announced its new iTind Center of Excellence (COE) program.

The program was designed to enhance care, experience, and outcomes, for men suffering from symptoms associated with benign prostatic hyperplasia (BPH), known as enlarged prostate. Urologists included in the program achieve a required level of training with the iTind procedure, are experienced in the procedure, and show high commitment to caring for their BPH patients.

In its inaugural year, the iTind Center of Excellence Program welcomes three members: C. Cragin Anderson, MD, FACS, a board-certified urologist with Colorado Urology; Petar Bajic, MD, a board-certified urologist and Director of Men’s Health at Glickman Urological Institute, Cleveland Clinic; and Alex M. Kandabarow, MD, a board-certified urologist with Virginia Hospital Center Health Urology – Kingstowne.

Benchmarks for achieving an iTind CEO status for a urologist treating patients with the iTind procedure include, but aren’t limited to:

• Completing a specialized iTind training program
• Upholding clinical proficiency by performing a minimum number of cases annually
• Providing de-identified patient data showing a mean improvement score based on FDA guidance for BPH treatments

“We are thrilled to welcome these inaugural members to the iTind Center of Excellence Program,” said Matt Woodward, VP and regional business lead for Urology at Olympus. “Patients suffering from enlarged prostate need to know that there are safe and effective alternatives to medications and invasive surgeries for relieving urinary symptoms that can seriously affect their quality of life. Our relationship with these physicians is centered on excellence in patient care and experience and aimed towards improving patient outcomes in BPH treatment.”